GlaxoSmithKline signed a memorandum of cooperation with Aikang group to carry out herpes zoster disease prevention education for middle-aged and elderly people

On October 25, GlaxoSmithKline and Aikang Group officially signed a memorandum of cooperation. They hope to jointly carry out the prevention and education of herpes zoster disease for the middle-aged and elderly people. The two sides will discuss how to give full play to their professional advantages in the field of health, organize a variety of activities and methods, such as herpes zoster disease education for the elderly, media publicity, information popularization of herpes zoster disease prevention for the elderly, and corporate social responsibility projects, so as to enhance the awareness of herpes zoster disease prevention of the middle-aged and the elderly, and jointly improve the health level of the elderly. < p > < p > Qi Xin, vice president of GlaxoSmithKline and general manager of prescription drugs and vaccines in China, and Zhang Ligang, founder, chairman and CEO of Aikang group, signed a memorandum of cooperation < / P > < p > by the end of 2019, the population aged 60 and above in China exceeded 250 million, accounting for 18.1% of the total population. In order to actively deal with the problem of aging, China put forward “promoting healthy aging” as an important strategic goal in the “healthy China 2030” planning outline, and launched a series of elderly health promotion actions. With the acceleration of aging process in China, the burden of herpes zoster disease in China is increasingly serious. According to statistics, there are about 1.56 million new cases of herpes zoster in Chinese people aged 50 and above every year. Herpes zoster is an infectious skin disease caused by reactivation of varicella zoster virus, which has been latent in the dorsal root ganglion or cranial ganglion for a long time. In addition to skin damage, herpes zoster can also cause burning, electric shock, knife like pain, acute pain may be more than labor pains, spinal cord injury, rheumatoid arthritis, chronic cancer pain and so on. The treatment of herpes zoster is limited. Vaccination is an effective way to prevent herpes zoster, which can significantly reduce the burden of herpes zoster. Xu Jinhua, director of Department of dermatology at Huashan Hospital Affiliated to Fudan University,

, said: “the incidence rate and severity of herpes zoster are increasing with age. This is especially evident after 50 years old. This is related to attenuation of cellular immune function related to age. Postherpetic neuralgia is the most common complication of herpes zoster. The pain of elderly patients with herpes zoster is more common and severe, more prone to anxiety, sleep disorders, seriously affecting the quality of life of the elderly In response to this cooperation, Qi Xin, vice president of GlaxoSmithKline and general manager of prescription drugs and vaccines in China, said: “GlaxoSmithKline, as a global health care company guided by science, has been in China for a hundred years and has always been committed to helping the Chinese people do more, feel more comfortable and live longer. The middle-aged and the elderly are one of the groups with high risk and heavy burden of infectious diseases. Through the cooperation with Aikang group, we will continue to pay attention to the health of the middle-aged and the elderly, transfer more knowledge about herpes zoster prevention to the elderly, enhance their awareness of disease prevention, improve their quality of life, and jointly help China realize “healthy aging.” Zhang Ligang, founder, chairman and CEO of Aikang group, also said: “as a leading enterprise in the domestic health examination and health management industry, Aikang group has always been committed to playing a greater value and role in disease prevention, and directly set up a vaccination center in the physical examination center to provide customers with physical examination services and vaccination services at the same time. This time, we will work with GlaxoSmithKline to enhance the awareness of herpes zoster among the middle-aged and elderly people. Through disease education and publicity, corporate social responsibility projects, Star Public Service videos and other activities, we will strive to achieve win-win cooperation in the field of health, so as to deepen the concept of disease prevention starting from vaccination, and make contributions to the early realization of “healthy China 2030.”